How is the cruel reality of mobile medical “and eggs†broken?
Recently, JAMA Internal Medicine published a study called BetterEffectivenessAfterTransition–HeartFailure (BEAT-HF), which focused on the analysis of the effects of patient intervention for cardiac discharge. A total of 1400 patients were divided into two groups, one with strong intervention and the other with no intervention. These patients were randomly selected from the population over 50 years old who were discharged after hospitalization due to heart disease in 2011-2013. Specific interventions include telephone guidance, monitoring of blood pressure, heart rate and weight, and the monitoring of data by the nurses and the intervention of patients. The results of the experiment showed that the readmission rate of the two groups was consistent within 180 days after discharge, which was 50%. There was no difference between the 30-day readmission rate and the 180-day mortality rate.
In the years after the booming mobile medical industry, the market's own reflections have become increasingly apparent as it has not achieved immediate results in the short term. At the same time, as the main buyer, the payment side's support for mobile medical care has always been kept at a small scale. The whole market is transitioning from an intensive investment period to a stable development, trying to find a more effective service model.
Such research shows that interventions that have been used as a means of mobile medical care do not improve and enhance the health of patients, nor do they provide truly effective fees for payers. Coincidentally, a survey recently announced by the Scripps Translational Science Institute also shows that short-term monitoring of wearable devices is difficult to control health effects and medical costs.
This type of research is not the first to be published. Although it can be questioned from the sample and the length of the research, the effect of mobile medical care is not very clear, which is undoubted. This is why mobile medical development is relatively advanced compared with telemedicine . It is slower. This poses a challenge to what value mobile healthcare can provide. In general, the value of mobile health care can interfere with the patient's condition, the drug company develops new drugs, and the payer controls medical expenses. However, from the above research, the effect is not obvious, and it is impossible to create sufficient value in the short term, which seriously affects the market's expectation for the future development of mobile medical care.
As a result, mobile healthcare and the resulting big data services cannot be quantified in the short term, nor can they achieve scale growth. The most likely way out of the future is to integrate it into traditional medical services, and to realize its value through long-term practice, and to promote the transformation and improvement of medical services.
From the current situation in China, basic medical care may be a very suitable entry point, rather than the current third-party service companies, third-party services have profit pressure, it is difficult to adhere to long-term. The basic medical institutions use it as a value-added service to enhance their medical service capabilities and promote their own development.
Before analyzing how basic healthcare can be combined with mobile healthcare, let's briefly review the multiple challenges facing basic health care: the lack of qualified doctors, the inability to provide one-stop medical services, and the willingness to pay.
COVID-19 Infectious Disease Test Kit
Corona viruses are enveloped RNA viruses that are distributed broadly among humans,other
mammals,and birds and that cause respiratory,enteric,hepatic and neurologic diseases.
COVID-19 infectious diseases test Kit
NINGBO AUTRENDS INTERNATIONAL TRADE CO., LTD , https://www.metests.com